Combinations comprising staurosporines

Details for Australian Patent Application No. 2004262927 (hide)

Owner Novartis AG

Inventors Bhalla, Kapil N.; Cohen, Pamela Sarah; Atadja, Peter Wisdom

Agent Davies Collison Cave

Pub. Number AU-B-2004262927

PCT Pub. Number WO2005/014004

Priority 60/493,828 08.08.03 US

Filing date 6 August 2004

Wipo publication date 17 February 2005

Acceptance publication date 22 May 2008

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014004 Priority application(s): WO2005/014004

22 May 2008 Application Accepted

  Published as AU-B-2004262927

18 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262933-Novel composition comprising rosiglitazone and another antidiabetic agent

2004262926-Composition for releasing a weak base for an extended period of time